Nutrien (NYSE:NTR – Get Free Report) had its price target raised by research analysts at UBS Group from $51.00 to $53.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s target price points to a potential upside of 1.12% from the company’s current price.
A number of other research analysts also recently weighed in on the company. TD Securities cut their price objective on Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research note on Tuesday, November 12th. Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $58.00 to $60.00 in a report on Tuesday, December 3rd. Barclays reiterated an “equal weight” rating and set a $56.00 price target (up from $55.00) on shares of Nutrien in a report on Tuesday, January 21st. Oppenheimer assumed coverage on Nutrien in a report on Thursday, December 12th. They set an “outperform” rating and a $60.00 price target for the company. Finally, CIBC reiterated an “outperformer” rating and set a $55.00 price target (down from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $58.94.
Read Our Latest Analysis on Nutrien
Nutrien Stock Down 0.2 %
Nutrien (NYSE:NTR – Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The company had revenue of $5.35 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the previous year, the business posted $0.35 earnings per share. The firm’s revenue was down 5.0% on a year-over-year basis. On average, equities research analysts expect that Nutrien will post 3.5 earnings per share for the current fiscal year.
Institutional Trading of Nutrien
A number of large investors have recently bought and sold shares of NTR. Silchester International Investors LLP grew its holdings in shares of Nutrien by 9.5% during the fourth quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company’s stock worth $523,268,000 after purchasing an additional 1,009,895 shares during the last quarter. ARGA Investment Management LP grew its holdings in shares of Nutrien by 25.7% during the fourth quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company’s stock worth $270,396,000 after purchasing an additional 1,236,671 shares during the last quarter. National Bank of Canada FI grew its holdings in shares of Nutrien by 4.1% during the third quarter. National Bank of Canada FI now owns 4,232,211 shares of the company’s stock worth $203,380,000 after purchasing an additional 165,582 shares during the last quarter. Toronto Dominion Bank boosted its holdings in Nutrien by 11.9% in the third quarter. Toronto Dominion Bank now owns 4,220,354 shares of the company’s stock valued at $202,830,000 after acquiring an additional 447,413 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new position in Nutrien in the third quarter valued at about $150,181,000. 63.10% of the stock is currently owned by institutional investors.
About Nutrien
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Read More
- Five stocks we like better than Nutrien
- Following Congress Stock Trades
- What Does the Future Hold for Eli Lilly?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- 3 Stocks to Consider Buying in October
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.